e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
New models for treating airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Antioxidant effects of bisphosphonates in smoking- induced lung injury in rat model
Celalettin Korkmaz (Konya, Turkey), Celalettin Korkmaz, Durdu Mehmet Yavsan, Soner Demirbas, Pembe Oltulu, Ibrahim Kilinç, Mehmet Uyar, Mehmet Gok, Kursat Uzun
Source:
International Congress 2015 – New models for treating airway diseases
Session:
New models for treating airway diseases
Session type:
Poster Discussion
Number:
3573
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Celalettin Korkmaz (Konya, Turkey), Celalettin Korkmaz, Durdu Mehmet Yavsan, Soner Demirbas, Pembe Oltulu, Ibrahim Kilinç, Mehmet Uyar, Mehmet Gok, Kursat Uzun. Antioxidant effects of bisphosphonates in smoking- induced lung injury in rat model. Eur Respir J 2015; 46: Suppl. 59, 3573
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The neurogenic inflammation markers in rat’s brain in experimental smoking
Source: International Congress 2016 – Molecular pathways of smoking-induced diseases
Year: 2016
The anti-inflammatory effects of PF03715455 and roflumilast on both cellular and tissue inflammation in a mouse model of COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Antioxidant activity of pomegranate juice reduces lung injury secondary to secondary to acute and chronic cigarette smoke exposure in an animal model
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
The anti-inflammatory effects of eucalyptol in a mouse model of LPS-induced pulmonary inflammation are mediated by TRPM8
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
Evaluation of antiinflammatory and antioxidant effect of mepenzolate in subacute cigarette exposure mouse model
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Tissue distribution of inhalation drugs in rat lung slices
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
The effects of clinically relevant reference agents in a mouse model of severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Acute protective effect of estradiol on lung inflammation induced by an intestinal ischemic insult in male rats
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
The role of lL-17 in the OVA-LPS driven model of lung inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
The effects of intra-nasally administered anti-inflammatory compounds in a mouse model of acute COPD exacerbations
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Therapeutic neutralization of the matrikine PGP suppresses the development of lung emphysema in cigarette smoke exposed mice
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Effects of prenatal tobacco smoke exposure on pulmonary signaling networks in a murine model
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
LATE-BREAKING ABSTRACT: Anti-inflammatory effects of diphenyleneiodonium in lipopolysaccharide-induced acute lung injury in rats
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015
Effects of chronic cigarette smoke exposure on lung inflammation in ovalbumin-sensitized mice
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Markers of cell proliferation contributes to the therapeutic effect of growth factor-LGF on experimental emphysema
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Implication of interleukin-10 in the development of COPD induced by cigarette smoke exposure in mice
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Effects of tobacco smoke and poly IC, alone and in combination, on mouse lung pathology
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept